Cited by 830Fibroblast Growth Factor ResearchAdipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated Receptors

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

Open access

Fisher, ffolliott M., Chui, Patricia C., Antonellis, Patrick J., Bina, Holly A., Kharitonenkov, Alexei, Flier, Jeffrey S., Maratos-Flier, Eleftheria·2010·Diabetes

DOI 10.2337/db10-0193PMC PMC2963536

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Fibroblast growth factor 21 (FGF21) is a key mediator of fatty acid oxidation and lipid metabolism. Pharmacological doses of FGF21 improve glucose tolerance, lower serum free fatty acids, and lead to weight loss in obese mice. Surprisingly, however, FGF21 levels are elevated in obese ob/ob and db/db mice and correlate positively with BMI in humans. However, the expected beneficial effects of endogenous FGF21 to increase glucose tolerance and reduce circulating triglycerides are absent in obesity. RESEARCH DESIGN AND METHODS: To test the hypothesis that obesity is a state of FGF21 resistance, we evaluated the response of obese mice to exogenous FGF21 administration. In doing this, we assessed the impact of diet-induced obesity on FGF21 signaling and resultant transcriptional events in the liver and white adipose tissue. We also analyzed the physiologic impact of FGF21 resistance by assessing serum parameters that are acutely regulated by FGF21. RESULTS: When obese mice are treated with FGF21, they display both a significantly attenuated signaling response as assessed by extracellular mitogen-activated protein kinase 1 and 2 (ERK1/2) phosphorylation as well as an impaired induction of FGF21 target genes, including cFos and EGR1. These effects were seen in both liver and fat. Similarly, changes in serum parameters such as the decline in glucose and free fatty acids are attenuated in FGF21-treated DIO mice. CONCLUSIONS: These data demonstrate that DIO mice have increased endogenous levels of FGF21 and respond poorly to exogenous FGF21. We therefore propose that obesity is an FGF21-resistant state.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/db10-0193

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Self-citation
Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Self-citation
Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Self-citation
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Self-citation
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Self-citation
The role of SOCS-3 in leptin signaling and leptin resistance
Bjørbæk, C., El-Haschimi, K., Frantz, J. D., & Flier, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30059 · Cited by 639
Self-citation

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 201–300 of 826

Preparation of PLA/chitosan nanoscaffolds containing cod liver oil and experimental diabetic wound healing in male rats study
Khazaeli, P., Alaei, M., Khaksari, M., & Ranjbar, M. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00737-9 · Cited by 61
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Wu, Y., Ren, Z., Zhu, S., Wu, Y., Wang, G., Zhang, H., Chen, W., He, Z., Ye, X.-L., & Zhai, Q. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00786-2 · Cited by 66
The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin – A biochemical study in rats subjected to experimental hyperlipidemia and obesity
Monika, P., & Geetha, A. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.07.001 · Cited by 61
FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes
Laeger, T., Baumeier, C., Wilhelmi, I., Würfel, J., Kamitz, A., & Schürmann, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4389-x · Cited by 59
Macroautophagy and Selective Mitophagy Ameliorate Chondrogenic Differentiation Potential in Adipose Stem Cells of Equine Metabolic Syndrome: New Findings in the Field of Progenitor Cells Differentiation
Marycz, K., Kornicka, K., Grzesiak, J., Śmieszek, A., & Szłapka‐Kosarzewska, J. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3718468 · Cited by 61
Glucagon's Metabolic Action in Health and Disease
Zeigerer, A., Sekar, R., Kleinert, M., Nason, S. R., Habegger, K. M., & Müller, T. D. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200013 · Cited by 87
Macronutrient Intake–Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial
Heianza, Y., Ma, W., Huang, T., Wang, T., Zheng, Y., Smith, S. R., Bray, G. A., Sacks, F. M., & Qi, L. (2016) · Diabetes Care · doi:10.2337/dc16-1111 · Cited by 60
Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice
Hughey, C. C., James, F. D., Bracy, D. P., Donahue, E. P., Young, J. D., Viollet, B., Foretz, M., & Wasserman, D. H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811547 · Cited by 56
miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction
Hu, Y. C., Liu, H., Jena, P. K., Sheng, L., Ali, M. R., & Wan, Y. Y. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100093 · Cited by 59
Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study
Watanabe, M., Risi, R., Camajani, E., Contini, S., Persichetti, A., Tuccinardi, D., Ernesti, I., Mariani, S., Lubrano, C., Genco, A., et al. (2020) · Nutrients · doi:10.3390/nu12072141 · Cited by 59
The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective
Liu, J., Foo, J. P., Liu, S., & Lim, S. C. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.032 · Cited by 58
Fibroblast Growth Factor 21 Protects Against High Glucose Induced Cellular Damage and Dysfunction of Endothelial Nitric-Oxide Synthase in Endothelial Cells
Wang, X., Song, S., Xiao, H., Gao, P., Li, X.-J., & Si, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363031 · Cited by 58
Diet polyphenol curcumin stimulates hepatic Fgf21 production and restores its sensitivity in high fat diet fed male mice
Zeng, K., Tian, L., Patel, R., Shao, W., Song, Z., Liu, L., Manuel, J., Ma, X., McGilvray, I. D., Cummins, C. L., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1596 · Cited by 57
FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis
Mottillo, E. P., Desjardins, E. M., Fritzen, A. M., Zou, V. Z., Crane, J. D., Yabut, J. M., Kiens, B., Erion, D. M., Lanba, A., Granneman, J. G., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.04.001 · Cited by 57
Sex differences in the development of hepatic steatosis in cafeteria diet-induced obesity in young mice
Gasparin, F. R. S., Carreño, F. O., Mewes, J. M., Gilglioni, E. H., Pagadigorria, C. L. S., Natali, M. R. M., Utsunomiya, K. S., Constantin, R. P., Ouchida, A. T., Curti, C., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.004 · Cited by 62
Association between serum FGF21 level and sarcopenia in older adults
Jung, H.-W., Park, J. H., Kim, D. A., Jang, I.-Y., Park, S. J., Lee, J. Y., Lee, S., Kim, J. H., Yi, H.-S., Lee, E., et al. (2021) · Bone · doi:10.1016/j.bone.2021.115877 · Cited by 55
A low-protein diet induces body weight loss and browning of subcutaneous white adipose tissue through enhanced expression of hepatic fibroblast growth factor 21 (FGF21)
Pérez‐Martí, A., Garcia‐Guasch, M., Tresserra‐Rimbau, A., Carrilho‐Do‐Rosário, A., Estruch, R., Salas‐Salvadó, J., Martínez‐González, M. Á., Lamuela‐Raventós, R., Marrero, P. F., Haro, D., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600725 · Cited by 56
Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice
Maekawa, R., Seino, Y., Ogata, H., Murase, M., Iida, A., Hosokawa, K., Joo, E., Harada, N., Tsunekawa, S., Hamada, Y., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.010 · Cited by 56
Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
Villarroya, J., Gallego-Escuredo, J. M., Delgado‐Anglés, A., Cairó, M., Moure, R., Mateo, M. G., Domingo, J. C., Domingo, P., Giralt, M., & Villarroya, F. (2018) · Aging Cell · doi:10.1111/acel.12822 · Cited by 56
Prevention and reversal of hepatic steatosis with a high-protein diet in mice
Garcia‐Caraballo, S., Comhair, T. M., Verheyen, F., Gaemers, I. C., Schaap, F. G., Houten, S. M., Hakvoort, T. B. M., Dejong, C. H. C., Lamers, W. H., & Köhler, E. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.003 · Cited by 56
Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway
Lei, Y., Li, N., He, Z., Zeng, X., Yan, N., Chen, J., Miao, P., Ying, Y., Lin, W. Y., Zhao, X., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1893-6 · Cited by 55
Hormone-like fibroblast growth factors and metabolic regulation
Long, Y. C., & Kharitonenkov, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.002 · Cited by 55
Self-citation
Defining “FGF21 Resistance” during obesity: Controversy, criteria and unresolved questions
Markan, K. R. (2018) · F1000Research · doi:10.12688/f1000research.14117.1 · Cited by 55
Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
Sun, H., Sherrier, M. C., & Li, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.625287 · Cited by 54
Phosphoinositides: Key modulators of energy metabolism
Bridges, D., & Saltiel, A. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.008 · Cited by 56
The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose–lipid metabolism in vitro
Li, K., Li, L., Yang, M., Liu, H., Boden, G. H., & Yang, G. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.026 · Cited by 55
Fibroblast growth factor 21 in chronic kidney disease
Suassuna, P. G. D. A., de Paula, R. B., Sanders‐Pinheiro, H., Moe, O. W., & Hu, M. C. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0550-y · Cited by 57
The nonhuman primate as a model for type 2 diabetes
Pound, L. D., Kievit, P., & Grove, K. L. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000043 · Cited by 54
Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction
Fletcher, J. A., Meers, G. M.-E., Laughlin, M. H., Ibdah, J. A., Thyfault, J. P., & Rector, R. S. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-091 · Cited by 53
Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis
Lee, J., Hong, S., Park, S. E., Rhee, E., Park, C., Oh, K.-W., Park, S. W., & Lee, W. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.011 · Cited by 52
Alterations in 3-Hydroxyisobutyrate and FGF21 Metabolism Are Associated With Protein Ingestion–Induced Insulin Resistance
Harris, L.-A. L. S., Smith, G. I., Patterson, B. W., Ramaswamy, R. S., Okunade, A. L., Kelly, S. C., Porter, L. C., Klein, S., Yoshino, J., & Mittendorfer, B. (2017) · Diabetes · doi:10.2337/db16-1475 · Cited by 52
Curcumin supplementation mitigates NASH development and progression in female Wistar rats
Cunningham, R. P., Moore, M. P., Moore, A. N., Healy, J. C., Roberts, M. D., Rector, R. S., & Martin, J. S. (2018) · Physiological Reports · doi:10.14814/phy2.13789 · Cited by 51
Inflammatory markers in children and adolescents with type 2 diabetes mellitus
Reinehr, T. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.006 · Cited by 53
The regulation of glucose and lipid homeostasis via PLTP as a mediator of BAT–liver communication
Sponton, C. H., Hosono, T., Taura, J., Jedrychowski, M. P., Yoneshiro, T., Wang, Q., Takahashi, M., Matsui, Y., Ikeda, K., Oguri, Y., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949828 · Cited by 55
Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism
Ozaki, Y., Saito, K., Nakazawa, K., Konishi, M., Itoh, N., Hakuno, F., Takahashi, S.-I., Kato, H., & Takenaka, A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515002846 · Cited by 51
Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats
Wang, W., Li, S., Ren, G., Zheng, W., Lu, Y., Yu, Y.-H., Xu, W.-J., Li, T.-H., Zhou, L., Liu, Y., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0433-5 · Cited by 52
Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease
Li, Q., Zhang, Y., Ding, D., Yang, Y., Chen, Q., Su, D., Chen, X., Yang, W., Qiu, J., & Ling, W. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2308 · Cited by 52
FGF21 Takes a Fat Bite
Cantó, C., & Auwerx, J. H. (2012) · Science · doi:10.1126/science.1222646 · Cited by 52
Adipokines as Clinically Relevant Therapeutic Targets in Obesity
Würfel, M., Blüher, M., Stümvoll, M., Ebert, T., Kovacs, P. L., Tönjes, A., & Breitfeld, J. (2023) · Biomedicines · doi:10.3390/biomedicines11051427 · Cited by 56
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression
Gliniak, C. M., Gordillo, R., Youm, Y., Lin, Q., Crewe, C., Zhang, Z., Field, B. C., Fujikawa, T., Virostek, M., Zhao, S., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.011 · Cited by 53
Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
Zhang, X., Hu, Y., Zeng, H., Li, L., Zhao, J., Zhao, J., Liu, F., Bao, Y., & Jia, W. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0190-7 · Cited by 51
Identification of 22 novel loci associated with urinary biomarkers of albumin, sodium, and potassium excretion
Zanetti, D., Rao, A. S., Gustafsson, S., Assimes, T. L., Montgomery, S. B., & Ingelsson, E. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.017 · Cited by 51
Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature
Kim, S., Choi, S., Dutta, M., Asubonteng, J. O., Polunas, M., Goedken, M. J., Gonzalez, F. J., Cui, J. Y., & Gyamfi, M. A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114698 · Cited by 52
Regulation of Energy Metabolism by Receptor Tyrosine Kinase Ligands
Zhao, M., Jung, Y., Jiang, Z., & Svensson, K. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00354 · Cited by 55
Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children
Bj, K., Kim, S. M., Kh, P., Hs, P., & Mantzoros, C. S. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.45 · Cited by 49
Fibroblast growth factor 21 ( FGF 21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF 21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre‐diabetic rats
Tanajak, P., Sa‐nguanmoo, P., Wang, X., Liang, G., Li, X., Jiang, C., Chattipakorn, S. C., & Chattipakorn, N. (2016) · Acta Physiologica · doi:10.1111/apha.12698 · Cited by 49
Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
Wu, G., Li, H., Fang, Q., Zhang, J., Zhang, M., Zhang, L., Wu, L., Hou, X., Lu, J., Bao, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05257-5 · Cited by 49
Revealing the role of peroxisome proliferator-activated receptor β/δ in nonalcoholic fatty liver disease
Zarei, M., Aguilar-Recarte, D., Palomer, X., & Vázquez‐Carrera, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154342 · Cited by 49
Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity
Long, X., Liu, D., Gao, Q., Ni, J., Qian, L., Ni, Y., Fang, Q., Jia, W., & Li, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773340 · Cited by 47
Fgf21 is required for cardiac remodeling in pregnancy
Redondo‐Angulo, I., Mas‐Stachurska, A., Sitges, M., Tinahones, F. J., Giralt, M., Villarroya, F., & Planavila, A. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx088 · Cited by 48
FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats
Sa‐nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Wang, X., Liang, G., Li, X., Jiang, C., Pratchayasakul, W., Chattipakorn, N., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.021 · Cited by 48
Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge
Liu, D., Pang, J., Shao, W., Gu, J., Zeng, Y., He, H. H., Ling, W., Qian, X., & Jin, T. (2021) · Hepatology · doi:10.1002/hep.31856 · Cited by 48
Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls
Vienberg, S. G., Brøns, C., Nilsson, E., Astrup, A., Vaag, A., & Andersen, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0039 · Cited by 47
Microbiota and bile acid profiles in retinoic acid-primed mice that exhibit accelerated liver regeneration
Liu, H., Hu, Y. C., & Wan, Y. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6665 · Cited by 46
Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway
Li, C. H., Tang, S. C., Wong, C. H., Wang, Y., Jiang, J., & Chen, Y. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.035 · Cited by 45
Constant-Moderate and High-Intensity Interval Training Have Differential Benefits on Insulin Sensitive Tissues in High-Fat Fed Mice
Martínez-Huenchullán, S., Ban, L. A., Luisa Fernanda Olaya, A., Maharjan, B. R., Williams, P. F., Tam, C. S., McLennan, S. V., & Twigg, S. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00459 · Cited by 47
Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESC
Savarese, G., Schiattarella, G. G., Lindberg, F., Anker, M. S., Bayés‐Genís, A., Bäck, M., Braunschweig, F., Bucciarelli‐Ducci, C., Butler, J., Cannata, A. N., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3676 · Cited by 52
Fibroblast growth factor 21 is required for beneficial effects of exercise during chronic high-fat feeding
Loyd, C., Magrisso, I. J., Haas, M., Balusu, S., Krishna, R., Itoh, N., Sandoval, D. A., Pérez–Tilve, D., Obici, S., & Habegger, K. M. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00456.2016 · Cited by 49
Fibroblast growth factor 21, assisted by elevated glucose, activates paraventricular nucleus NUCB2/Nesfatin-1 neurons to produce satiety under fed states
Santoso, P., Nakata, M., Shiizaki, K., Boyang, Z., Parmila, K., Otgon-Uul, Z., Hashimoto, K., Satoh, T., Mori, M., Kuro‐o, M., et al. (2017) · Scientific Reports · doi:10.1038/srep45819 · Cited by 45
Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy
Rupérez, C., Lerín, C., Ferrer‐Curriu, G., Cairó, M., Mas‐Stachurska, A., Sitges, M., Villarroya, J., Giralt, M., Villarroya, F., & Planavila, A. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.109 · Cited by 47
Lyophilized Maqui (Aristotelia chilensis) Berry Induces Browning in the Subcutaneous White Adipose Tissue and Ameliorates the Insulin Resistance in High Fat Diet-Induced Obese Mice
Sandoval, V., Femenias, A., Martínez‐Garza, Ú., Sanz‐Lamora, H., Castagnini, J. M., Quifer‐Rada, P., Lamuela-Raventós, R. M., Marrero, P. F., Haro, D., & Relat, J. (2019) · Antioxidants · doi:10.3390/antiox8090360 · Cited by 46
Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice
Félix‐Soriano, E., Sáinź, N., Gil‐Iturbe, E., Collantes, M., Fernández‐Galilea, M., Castilla‐Madrigal, R., Ly, L., Dalli, J., & Moreno-Aliaga, M. J. (2021) · The FASEB Journal · doi:10.1096/fj.202002531r · Cited by 47
High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids
Garcia‐Caraballo, S., Comhair, T. M., Houten, S. M., Dejong, C. H. C., Lamers, W. H., & Köhler, E. S. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.07.005 · Cited by 45
Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels
Fang, Q., Li, H., Song, Q., Yang, W. J., Hou, X., Ma, X., Lu, J., Xu, A., & Jia, W. (2013) · Diabetes Care · doi:10.2337/dc12-1766 · Cited by 45
Metabolic actions of fibroblast growth factor 21
Ramos, D. C., Aguilar-Salinas, C. A., & Gomez-Perez, F. J. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283557d22 · Cited by 46
Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice
Zhao, C., Liu, L., Liu, Q., Li, F., Zhang, L., Zhu, F., Shao, T., Barve, S. S., Chen, Y., Li, X., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.020 · Cited by 47
Fibroblast growth factor 21 in heart failure
Tucker, W., Tucker, B., Rye, K., & Ong, K. L. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10268-0 · Cited by 44
Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
Yu, Y., Zhang, X. H., Ebersole, B., Ribnicky, D., & Wang, Z. Q. (2013) · Scientific Reports · doi:10.1038/srep03142 · Cited by 46
Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up
Lenart-Lipińska, M., Matyjaszek‐Matuszek, B., Gernand, W., Nowakowski, A. M., & Solski, J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.010 · Cited by 44
Potential of incretin-based therapies for non-alcoholic fatty liver disease
Samson, S. L., & Bajaj, M. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.12.005 · Cited by 44
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21
Camporez, J. P., Asrih, M., Zhang, D., Kahn, M., Samuel, V. T., Jurczak, M. J., & Jornayvaz, F. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0136 · Cited by 44
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
Lee, C., Woo, Y. C., Chow, W. S., Cheung, C. Y. Y., Fong, C. H. Y., Yuen, M. M. A., Xu, A., Tse, H., & Lam, K. S. L. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005344 · Cited by 45
Liver-derived FGF21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis
Watanabe, M., Singhal, G., Fisher, F. M., Beck, T. C., Morgan, D. A., Socciarelli, F., Mather, M. L., Risi, R., Bourke, J., Rahmouni, K., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02124-3 · Cited by 44
Self-citation
The physiology of MASLD: molecular pathways between liver and adipose tissues
Lee, W., Kipp, Z. A., Bates, E. A., Pauss, S. N., Martinez, G. J., & Hinds, T. D. (2025) · Clinical Science · doi:10.1042/cs20257571 · Cited by 52
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease
Kralisch, S., & Faßhauer, M. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328346a326 · Cited by 44
Plasma levels of myonectin but not myostatin or fibroblast-derived growth factor 21 are associated with insulin resistance in adult humans without diabetes mellitus
Toloza, F. J. K., Mantilla-Rivas, J. O., Pérez-Matos, M. C., Ricardo-Silgado, M. L., Morales-Alvarez, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., Arévalo-Garcia, M. L., Tolosa-González, G., & Mendivil, C. O. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00005 · Cited by 42
Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review
Porflitt-Rodríguez, M., Guzmán-Arriagada, V., Sandoval-Valderrama, R., Tam, C. S., Pavicic, F., Ehrenfeld, P., & Martínez-Huenchullán, S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155137 · Cited by 42
Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
Raptis, D. D., Mantzoros, C., & Polyzos, S. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s352008 · Cited by 31
Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes
Reinehr, T., Karges, B., Meißner, T., Wiegand, S., Fritsch, M., Holl, R. W., & Woelfle, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2192 · Cited by 42
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes
Donate‐Correa, J., Martín‐Núñez, E., Pérez‐Delgado, N., de Fuentes, M. M., Ortíz, A., Fernández, C. M., & Navarro‐González, J. F. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.12.003 · Cited by 44
Curcumin and dietary polyphenol research: beyond drug discovery
Jin, T. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.179 · Cited by 43
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Agrawal, A., Parlee, S. D., Pérez–Tilve, D., Li, P., Pan, J. H., Mroz, P. A., Hansen, A. M. K., Andersen, B., Finan, B., Kharitonenkov, A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.003 · Cited by 42
Self-citation
Protein intake and amino acid supplementation regulate exercise recovery and performance through the modulation of mTOR, AMPK, FGF21, and immunity
Torre-Villalvazo, I., Alemán, G., Valle‐Rios, R., & Noriega, L. G. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.06.006 · Cited by 45
The roles of FGF21 in atherosclerosis pathogenesis
Shanehbandpour-Tabari, F., Karimian, A., Parsian, H., Rameshknia, V., Mahmoodpoor, A., Majidinia, M., Maniati, M., & Yousefi, B. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09488-x · Cited by 41
β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 43
The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets
Norwitz, N. G., Soto-Mota, A., Kaplan, B., Ludwig, D. S., Budoff, M. J., Kontush, A., & Feldman, D. (2022) · Metabolites · doi:10.3390/metabo12050460 · Cited by 41
Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia
Stepan, H., Kley, K., Hindricks, J., Kralisch, S., Jank, A., Schaarschmidt, W., Schrey-Petersen, S., Ebert, T., Lössner, U., Kratzsch, J., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.02.019 · Cited by 40
Cardiorespiratory Fitness and Visceral Fat Are Key Determinants of Serum Fibroblast Growth Factor 21 Concentration in Japanese Men
Taniguchi, H., Tanisawa, K., Sun, X., Cao, Z., Oshima, S., Ise, R., Sakamoto, S., & Higuchi, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1877 · Cited by 40
Stress Signaling Between Organs in Metazoa
Owusu-Ansah, E., & Perrimon, N. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125523 · Cited by 39
FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats
He, J., Zhao, M., Xia, J.-J., Guan, J., Liu, Y., Wang, L.-Q., Song, D.-X., Qu, M.-Y., Zuo, M., Wen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep29582 · Cited by 41
Fibroblast growth factor 21 in chronic kidney disease
Anuwatmatee, S., Tang, S., Wu, B. J., Rye, K., & Ong, K. L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.002 · Cited by 40
Multiomics and digital monitoring during lifestyle changes reveal independent dimensions of human biology and health
Marabita, F., James, T., Karhu, A., Virtanen, H., Kettunen, K., Stenlund, H. C., Boulund, F., Hellström, C., Neiman, M., Mills, R., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.11.001 · Cited by 39
Evaluation of Total Adiponectin, Adipocyte Fatty Acid Binding Protein and Fibroblast Growth Factor 21 Levels in Individuals With Metabolic Syndrome
Novotný, D., Vaverková, H., Karásek, D., Lukeš, J., Slavík, L., Malina, P., & Orság, J. (2014) · Physiological Research · doi:10.33549/physiolres.932602 · Cited by 39
Exercise ameliorates the FGF21–adiponectin axis impairment in diet-induced obese mice
Yang, W., Liu, L., Wei, Y., Fang, C., Zhou, F., Chen, J., Han, Q., Huang, M., Tan, X., Liu, Q., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0034 · Cited by 39
FGF21 and Chronic Kidney Disease.
Salgado, J., Goes, M. A., & Salgado, N. (2021) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2021.154738 · Cited by 35
Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity
Claflin, K. E., Sullivan, A. I., Naber, M. C., Flippo, K. H., Morgan, D. A., Neff, T. J., Jensen-Cody, S. O., Zhu, Z., Zingman, L. V., Rahmouni, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101564 · Cited by 37
Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
Patel, S., Haider, A., Álvarez-Guaita, A., Bidault, G., Moustafa, J. S. E.-S., Guiu‐Jurado, E., Tadross, J. A., Warner, J., Harrison, J., Virtue, S., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101589 · Cited by 42
Incretin based therapies: A novel treatment approach for non-alcoholic fatty liver disease
Blaslov, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7356 · Cited by 39
FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity
Minami, S., Sakai, S., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Yonishi, H., Nakamura, J., Maeda, S., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2259282 · Cited by 39
Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways
Rebollo‐Hernanz, M., Aguilera, Y., Martin-Cabrejas, M. A., & de Mejı́a, E. G. (2022) · Antioxidants · doi:10.3390/antiox11010136 · Cited by 37

Authors: Fisher, F. M., Chui, P. C., Antonellis, P. J., Bina, H. A., Kharitonenkov, A., Flier, J. S., & Maratos-Flier, E.
Affiliations: Beth Israel Deaconess Medical Center (US)
Eli Lilly (United States) (US)
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts;
ORCID: Antonellis, Patrick J.
Kharitonenkov, Alexei
Flier, Jeffrey S.
Venue: Diabetes
Publisher: American Diabetes Association
Published: 2010-08-03
Volume: 59
Issue: 11
Pages: 2781-2789
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/db10-0193
PMC: PMC2963536
OpenAlex: W2134944069
Cited by: 830
References: 30
Citations by year: 2026: 31 · 2025: 61 · 2024: 62 · 2023: 54 · 2022: 66 · 2021: 59 · 2020: 50 · 2019: 56 · 2018: 58 · 2017: 74 · 2016: 60 · 2015: 51 · 2014: 45 · 2013: 29 · 2012: 47
FWCI: 13.19
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 4042 d)
Locations: Diabetes (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R37DK028082)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords: FGF21, FGF21 resistance, obesity, diet-induced obesity, ERK1/2 phosphorylation, c-fos, EGR1, liver, white adipose tissue, glucose tolerance, free fatty acids, lipid metabolism, ob/ob mice, db/db mice
MeSH terms: Adipose Tissue, Animals, Drug Resistance, Fibroblast Growth Factors, Humans, Injections, Intravenous, Liver, Mice, Inbred C57BL, Mice, Obese, Obesity, Recombinant Proteins, RNA, Messenger, Signal Transduction, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinase 3, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks